Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials
Clinical and Translational Medicine - Wiley Online Library
IJMS | Free Full-Text | Mechanisms of Multidrug Resistance in Cancer Chemotherapy | HTML
Frontiers | The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents | Pharmacology
Are cancer patients better off if they participate in clinical trials? A mixed methods study | BMC Cancer | Full Text
Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials
Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials
Americans Can't Keep Up with High Cost of Cancer Treatment
Home Page ::: Clinical Cancer Drugs (Discontinued)
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received | Journal of Clinical Oncology
The high price of anticancer drugs: origins, implications, barriers, solutions | Nature Reviews Clinical Oncology
Mortality due to cancer treatment delay: systematic review and meta-analysis | The BMJ
Frontiers | Probiotics in Cancer | Oncology
The State of Cancer Care in America, 2017: A Report by the American Society of Clinical Oncology | JCO Oncology Practice
Investigating the Side Effects of Cancer Immunotherapy - NCI
Home Page ::: Anti-Cancer Agents in Medicinal Chemistry
Clinical Cancer Drugs
Home Page ::: Current Cancer Drug Targets
Clinical Cancer Research - Wikipedia
Home Page: Clinical Oncology
Regulatory and clinical consequences of negative confirmatory trials of accelerated approval cancer drugs: retrospective observational study | The BMJ
Risks and benefits of anticancer drugs in advanced cancer patients: A systematic review and meta-analysis - eClinicalMedicine
Overcoming cancer therapeutic bottleneck by drug repurposing | Signal Transduction and Targeted Therapy
The State of Cancer Care in America, 2017: A Report by the American Society of Clinical Oncology | JCO Oncology Practice
Understanding Pharmacogenomics | Cancer.Net
Drug resistance and combating drug resistance in cancer